Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jul;34(7):1587-1598.
doi: 10.1002/ptr.6637. Epub 2020 Feb 18.

Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials

Marzieh Mahmoodi  1 , Razieh Hosseini  2 , Asma Kazemi  3 , Richard Ofori-Asenso  4   5 , Mohsen Mazidi  6 , Seyed Mohammad Mazloomi  3   7
Affiliations
Meta-Analysis

Effects of green tea or green tea catechin on liver enzymes in healthy individuals and people with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized clinical trials

Marzieh Mahmoodi et al. Phytother Res. 2020 Jul.

Abstract

The therapeutic potential of green tea as a rich source of antioxidants and anti-inflammatory compounds has been investigated by several studies. The present study aimed to systematically review and analyze randomized clinical trials (RCTs) assessing the effects of green tea, catechin, and other forms of green tea supplementation on levels of liver enzymes. PubMed, SCOPUS, EMBASE, and Cochrane databases were searched until February 2019. All RCTs investigating the effect of green tea or its catechin on liver enzymes including alanine transaminase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and bilirubin were included. A total of 15 RCTs were included. The overall effect of green tea on liver enzymes was nonsignificant (ALT [Standardized mean difference (SMD)= -0.17, CI -0.42 to 0.08, p = .19], AST [SMD = -0.07, CI -0.43 to 0.29, p = .69], and ALP [SMD = -0.17, CI -0.45 to 0.1, p = .22]). However, subgroup analyses showed that green tea reduced the levels of liver enzymes in participants with nonalcoholic fatty liver disease (NAFLD) but in healthy subjects, a small significant increase in liver enzymes was observed. In conclusion, the results of this study suggest that the effect of green tea on liver enzymes is dependent on the health status of individuals. While a moderate reducing effect was observed in patients with NAFLD, in healthy subjects, a small increasing effect was found.

Keywords: green tea; liver enzyme; meta-analysis.

PubMed Disclaimer

References

REFERENCES

    1. Chen, T.-S., Liou, S.-Y., Wu, H.-C., Tsai, F.-J., Tsai, C.-H., Huang, C.-Y., & Chang, Y.-L. (2011). Efficacy of epigallocatechin-3-gallate and amla (Emblica officinalis) extract for the treatment of diabetic-uremic patients. Journal of Medicinal Food, 14, 718-723.
    1. Church, R. J., Gatti, D. M., Urban, T. J., Long, N., Yang, X., Shi, Q., … Churchill, G. A. (2015). Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food and Chemical Toxicology, 76, 19-26.
    1. Emoto, Y., Yoshizawa, K., Kinoshita, Y., Yuki, M., Yuri, T., Yoshikawa, Y., … Tsubura, A. (2014). Green tea extract-induced acute hepatotoxicity in rats. Journal of Toxicologic Pathology, 27, 163-174.
    1. Forester, S. C., & Lambert, J. D. (2011). The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Molecular Nutrition & Food Research, 55, 844-854.
    1. Frank, J., George, T. W., Lodge, J. K., Rodriguez-Mateos, A. M., Spencer, J. P., Minihane, A. M., & Rimbach, G. (2008). Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. The Journal of Nutrition, 139, 58-62.

MeSH terms

LinkOut - more resources